Saira Ramasastry - Jun 2, 2025 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Role
Director
Signature
/s/ Judit Ryvkin, Attorney-in-Fact
Stock symbol
MIRM
Transactions as of
Jun 2, 2025
Transactions value $
-$342,543
Form type
4
Date filed
6/4/2025, 04:11 PM
Previous filing
Jun 2, 2025
Next filing
Sep 10, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Ramasastry Saira Director C/O MIRUM PHARMACEUTICALS, INC., 989 E HILLSDALE BLVD., SUITE 300, FOSTER CITY /s/ Judit Ryvkin, Attorney-in-Fact 2025-06-04 0001547959

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MIRM Common Stock Sale -$263K -5.7K -100% $46.20 0 Jun 2, 2025 Direct
transaction MIRM Common Stock Options Exercise $35.3K +2.5K $14.12 2.5K Jun 3, 2025 Direct
transaction MIRM Common Stock Sale -$114K -2.5K -100% $45.74 0 Jun 3, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MIRM Stock Option (right to buy) Options Exercise $0 -2.5K -100% $0.00 0 Jun 3, 2025 Common Stock 2.5K $14.12 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.